Earlier, Shankar et al. (2013) described that EGCG treatment inhibited pancreatic cancer in Balb C nude mice through downregulating AKT, ERK, PI3K, and FKHRL1/FOXO3a, and modulating FOXO genes. This evidence concerns the gene AKT1 and familial pancreatic carcinoma.